These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 24184811)

  • 1. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
    Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
    Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
    Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
    Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21.
    Sun Y; Xia M; Yan H; Han Y; Zhang F; Hu Z; Cui A; Ma F; Liu Z; Gong Q; Chen X; Gao J; Bian H; Tan Y; Li Y; Gao X
    Br J Pharmacol; 2018 Jan; 175(2):374-387. PubMed ID: 29065221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholic Acid Supplementation of a High-Fat Obesogenic Diet Suppresses Hepatic Triacylglycerol Accumulation in Mice via a Fibroblast Growth Factor 21-Dependent Mechanism.
    Ippagunta SM; Kharitonenkov A; Adams AC; Hillgartner FB
    J Nutr; 2018 Apr; 148(4):510-517. PubMed ID: 29659970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis.
    Lee J; Hong SW; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
    Metabolism; 2014 Aug; 63(8):1041-8. PubMed ID: 24933399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
    Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
    Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid receptor β stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice.
    Li Y; Wong K; Walsh K; Gao B; Zang M
    J Biol Chem; 2013 Apr; 288(15):10490-504. PubMed ID: 23430257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
    Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
    Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
    Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
    Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
    Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
    Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
    Yano K; Yamaguchi K; Seko Y; Okishio S; Ishiba H; Tochiki N; Takahashi A; Kataoka S; Okuda K; Liu Y; Fujii H; Umemura A; Moriguchi M; Okanoue T; Itoh Y
    Lab Invest; 2022 Mar; 102(3):281-289. PubMed ID: 34732847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary medium-chain fatty acids reduce hepatic fat accumulation via activation of a CREBH-FGF21 axis.
    Cao Y; Araki M; Nakagawa Y; Deisen L; Lundsgaard A; Kanta JM; Holm S; Johann K; Brings Jacobsen JC; Jähnert M; Schürmann A; Kiens B; Clemmensen C; Shimano H; Fritzen AM; Kleinert M
    Mol Metab; 2024 Sep; 87():101991. PubMed ID: 39019116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice.
    Sun W; Nie T; Li K; Wu W; Long Q; Feng T; Mao L; Gao Y; Liu Q; Gao X; Ye D; Yan K; Gu P; Xu Y; Zhao X; Chen K; Loomes KM; Lin S; Wu D; Hui X
    Diabetes; 2021 Oct; ():. PubMed ID: 34957498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk
    Sun W; Nie T; Li K; Wu W; Long Q; Feng T; Mao L; Gao Y; Liu Q; Gao X; Ye D; Yan K; Gu P; Xu Y; Zhao X; Chen K; Loomes KM; Lin S; Wu D; Hui X
    Diabetes; 2021 Oct; ():. PubMed ID: 34675003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice.
    Krumm CS; Xu X; Bare CJ; Holman CD; Kersten S; Dow LE; Lee AH; Cohen DE
    J Biol Chem; 2021 Jul; 297(1):100815. PubMed ID: 34023388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preemptive Activation of the Integrated Stress Response Protects Mice From Diet-Induced Obesity and Insulin Resistance by Fibroblast Growth Factor 21 Induction.
    Xu X; Krumm C; So JS; Bare CJ; Holman C; Gromada J; Cohen DE; Lee AH
    Hepatology; 2018 Dec; 68(6):2167-2181. PubMed ID: 29698569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.